The Latest: Other opioid claims move ahead amid bankruptcy

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Purdue Pharma, the company which makes OxyContin and other drugs, filed court papers in New York on Sunday, Sept. 15, 2019, seeking Chapter 11 bankruptcy protection. (AP Photo/Toby Talbot, File)
FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. The company, which makes OxyContin and other drugs, filed court papers in New York on Sunday, Sept. 15 seeking Chapter 11 bankruptcy protection. (AP Photo/Frank Franklin II, File)
FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. The company, which makes OxyContin and other drugs, filed court papers in New York on Sunday, Sept. 15 seeking Chapter 11 bankruptcy protection. (AP Photo/Frank Franklin II, File)
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)

The Latest on Purdue Pharmas bankruptcy filing (all times local):

10 a.m.

The lead lawyers for local governments suing drug companies over the opioid crisis say the OxyContin maker Purdue Pharma's bankruptcy filing won't stop a trial scheduled for next month against other parts of the drug industry.

Purdue filed for bankruptcy late Sunday night as part of a settlement plan. Lead lawyers for the local governments suing the company and others support the settlement, as do attorneys general for about half the states.

Other states oppose the plan and say they'll fight it in court. The first court proceeding in Purdue's bankruptcy case is expected Tuesday in White Plains, New York.

The lawyers for the local governments say the first federal trial on the matter scheduled to start Oct. 21 in Cleveland should still move ahead.

___

2 a.m.

OxyContin maker Purdue Pharma has filed for bankruptcy protection.

But that doesn't mean the company or the family that owns it is off the legal hook.

States are divided on whether to accept a tentative settlement with the company as part of the bankruptcy.

Several of those who have declined it have made it clear that they plan to object to the bankruptcy and push forward with their claims against members of the Sackler family in state court.

It will be up to a bankruptcy judge to decide if those suits can move ahead. And even if he stops them, he could consider their claims in his court.

The bankruptcy filing Sunday will likely get Purdue out of a trial over the toll of opioids scheduled for October in Cleveland.

___

Mulvihill reported from Cherry Hill, New Jersey.

___

Follow Geoff Mulvihill at http://www.twitter.com/geoffmulvihill

Other News

Asian stocks drift pending fresh news; oil takes a breather

Aug 16, 2016

Asian stock markets drifted sideways on Tuesday as the price of oil took a breather from a three-day rally

Insurers continue to abandon ACA exchanges, limiting choice

Aug 16, 2016

Aetna will abandon for next year Affordable Care Act insurance exchanges in more than two-thirds of the counties where it sells coverage, making it the latest major health insurer to cuts choices in many markets

Conventional tax proposals in an unconventional US campaign

Aug 17, 2016

In this unconventional campaign season, Donald Trump and Hillary Clinton have produced two conventional tax plans that mostly track their parties' long-standing views

The Budget Report seeks to provide comprehensive coverage and analysis on the current economic, financial issues around the world. First hand finance and economic news all day, every day.